v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (38,394) $ (61,772)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization, and impairments 5,086 6,327
Non-cash interest expense 844 1,099
Write-down of inventories 0 7,931
Write-down of vendor advances 0 9,621
Stock-based compensation expense 19,312 17,074
Change in fair value of warrant liabilities (413) (1,652)
Other 1,375 346
Changes in operating assets and liabilities:    
Accounts receivable (11,999) (3,972)
Inventories 1,805 626
Prepaid expenses and other assets (13,209) (1,114)
Vendor advances (649) 3,208
Accounts payable 154 (943)
Deferred revenue (9,241) 832
Accrued purchase commitments (131) 0
Change in operating lease assets and liabilities (698) (633)
Accrued expenses and other liabilities 13,729 1,291
Net cash used in operating activities (32,429) (21,731)
Cash flows from investing activities:    
Purchases of property, equipment, and intangible assets, including capitalized software (3,069) (2,265)
Net cash used in investing activities (3,069) (2,265)
Cash flows from financing activities:    
Proceeds from exercise of stock options 6,084 274
Proceeds from employee stock purchase plan 1,233 949
Net proceeds from share offering 0 81,006
Payments to tax authorities for restricted stock units withheld (7) (2,775)
Net cash provided by financing activities 7,310 79,454
Net increase (decrease) in cash, cash equivalents, and restricted cash (28,188) 55,458
Cash, cash equivalents, and restricted cash, beginning of period 154,504 92,790
Cash, cash equivalents, and restricted cash, end of period $ 126,316 $ 148,248